These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36889247)

  • 1. Biological evaluation of a novel stable peptide PET molecular probe [
    Yao B; Wang L; Xie C; Li M; Peng C; Li Z; Lu W; Chen J
    Nucl Med Biol; 2023; 118-119():108330. PubMed ID: 36889247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of [
    Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S
    Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of CXCR4 expression using [
    Cheng K; Wang S; Liu T; Pei J; Wang S; Liu J; Zhao K; Luo Y; Xu S; Yu J; Liu J
    Theranostics; 2024; 14(16):6337-6349. PubMed ID: 39431004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second generation Al
    Spahn MA; Luyten K; Van Loy T; Sathekge M; Deroose CM; Koole M; Schols D; Vanduffel W; De Vos K; Annaert P; Bormans G; Cleeren F
    Nucl Med Biol; 2024; 132-133():108906. PubMed ID: 38518400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
    Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of renal clearance of [
    Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and preclinical evaluation of a novel molecular probe [
    Sun P; Mo C; Bai L; Wang M; Chen Z; Zhang M; Han Y; Liang H; Tang G
    Bioorg Chem; 2024 Apr; 145():107193. PubMed ID: 38442611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and preclinical evaluation of a novel probe [
    Mo C; Sun P; Liang H; Chen Z; Wang M; Fu L; Huang S; Tang G
    Bioorg Chem; 2024 Jun; 147():107352. PubMed ID: 38640719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Preclinical Evaluation of [
    Liang H; Chen Z; Mo C; Tang G
    J Labelled Comp Radiopharm; 2024 Aug; 67(10):334-340. PubMed ID: 39041590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A
    PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High in-vivo stability in preclinical and first-in-human experiments with [
    Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Wang Y; Zhang Y; Chen Y; Wang S; Liu W; Liu Z; Hu M
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3161-3175. PubMed ID: 38713298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor targeting efficacy of a novel PET radiotracer (1)8F-AlF-NOTA-PRGD2 in mice].
    Wu H; Wang Q; Han Y; Zhou W; Li H; Tian Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):51-5. PubMed ID: 24463116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
    Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M
    J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Al[
    Alonso Martinez LM; Harel F; Nguyen QT; Létourneau M; D'Oliviera-Sousa C; Meloche B; Finnerty V; Fournier A; Dupuis J; DaSilva JN
    Nucl Med Biol; 2018 Dec; 67():36-42. PubMed ID: 30388434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.